"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in ...

Aspirin 81mg tabs, 325mg caplets; e-c. To reduce combined risk of death and nonfatal stroke after ischemic stroke or TIA. To reduce risk of vascular mortality in suspected acute MI. To reduce ...

The rationale for prescribing aspirin to patients with or at risk ... a small and uncomplicated myocardial infarction requiring hospitalization, or the development of new Q-waves indicating ...

Expert Rev Cardiovasc Ther. 2012;10(4):433-439. This article suggests the need to reconsider the benefits of using aspirin in stroke prevention, especially in low-risk patients or patients not ...

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.